Which of the following patients are receiving treatment that has been developed utilizing recombinant DNA techniques? Select all that apply

Question

A)
Patient undergoing detection of gene location by chemically tagging DNA or RNA sequences
B)
Mother undergoing amniocentesis to diagnose a congenital adrenal hyperplasia
C)
End-stage renal disease patient receiving erythropoietin to stimulate RBC production
D)
Stroke victim receiving tissue plasminogen activator (tPA) to dissolve the thrombi
E)
Couple going to an infertility clinic for diagnostic testing

Answer 1

Ans:
C, D

Feedback:

Recombinant DNA technology has made it possible to produce proteins that have therapeutic properties. These include erythropoietin, which is used to stimulate RBC production, and tissue plasminogen activator (tPA), which is frequently administered to dissolve thrombi. In situ hybridization involves the use of specific sequences of DNA/RNA to locate genes. Prenatally, the autosomal recessive disorder congenital adrenal hyperplasia is diagnosed through amniocentesis.